CallWhatsApp
Book
Subsidy SetuMSME subsidy and compliance

Project report guide · Healthcare and pharma

Project report for a healthcare or pharma unit: what banks expect

Healthcare, pharmaceutical and medical-device businesses operate in a regulated environment, where product approvals, good manufacturing practice or equivalent quality systems and consistent testing are conditions for sale.
Build your DPR freeTalk to our expert team

In this guide

  • How the unit works, step by step
  • Inputs, utilities and approvals
  • Customers, staff and risks
  • The 24 sections of a bank-format DPR
  • A worked cost of project (illustrative)
  • 32 open Haryana and Central schemes

What the bank reads first

A bank or a subsidy department reads a project report for a healthcare or pharma unit to answer three questions: does the promoter understand how the business works, do the costs and projections hang together, and can the loan be repaid from the cash the unit earns. This guide sets out what such a report covers for this sector, in the order of the 24-section bank format our free DPR builder produces.

The sector notes below come from the library our DPR builder uses to write the descriptive sections of a report. They describe how such a unit usually works; they carry no market size, growth rate or typical cost, because those have to come from the promoter's own enquiries and quotations. The schemes are taken from our catalogue, open on the date the page was built, and are named with each scheme's own ceiling.

The sector in brief

Cost control, documentation and regulatory compliance determine profitability, and buyers such as hospitals, distributors and institutions value dependable quality and supply.

How the work is done

The process the “Products and Process” section of the report describes, in order.

  1. Procurement of approved raw materials and packing material from qualified suppliers.
  2. Testing and release of incoming materials by the quality-control laboratory.
  3. Production in a controlled area following written procedures and batch records.
  4. In-process controls and testing of the finished product against the specification.
  5. Packing and labelling as required for the product, and release by the quality function.
  6. Storage under the specified conditions and dispatch to distributors and buyers.

A quality-control laboratory and documented quality system will test materials and products, maintain batch records and handle complaints and recalls, in line with the licence conditions for the product.

Raw materials and utilities

Typical inputs: active ingredients, excipients, components or consumables approved for the product, and packing material.

Materials will be bought only from qualified suppliers whose material meets the specification, with more than one approved source for critical inputs where possible.

  • Electricity with back-up for production and storage.
  • Purified water or other process water, as the product requires.
  • Controlled-environment systems (air handling, temperature and humidity control) where the process requires them.

Approvals the report should name

In addition to Udyam, GST and the power and local-body approvals for the premises. Typically required where applicable; whether each applies depends on the size, location and activity, and is to be confirmed for the project.

  • Manufacturing licence from the State drug control authority, or registration and licence for medical devices under the central regulator, as applicable to the product.
  • Consent to Establish and Consent to Operate from the State Pollution Control Board, where the activity falls within its consent categories.
  • Factory licence under the State factory rules, where applicable.
  • Fire safety no-objection certificate, where required for the building or the materials stored.

Market, customers and staff

Customers
Distributors, hospitals, clinics, pharmacies, institutions and larger healthcare companies.
How it sells
A distributor network, direct supply to hospitals and institutions, tenders and contract manufacturing for larger companies.
What wins orders
Buyers choose on approved quality, consistent supply, regulatory standing and price.
Employment profile
The workforce will include qualified technical staff for production and quality control as required by the licence, operators and helpers, and staff for regulatory affairs, accounts and sales.

Risks a lender will ask about

The risks the sector library gives the SWOT section of the report, each with the way the project handles it.

Sector risks and how they are handled
RiskHow the project handles it
Delay in product licences and approvalsEarly filing of applications and professional regulatory support.
Quality failuresA documented quality system, trained staff and testing of every batch.
Price pressure from larger producersFocus on niche products, service and reliable supply.

Opportunities the report can point to

  • Contract manufacturing for larger companies.
  • Supply to hospitals and institutions through tenders.
  • Adding products under the same licence and quality system.

The 24 sections of a bank-format DPR

The structure our free DPR builder produces for every sector, after the cover page and contents.

The project and the promoter

Who is setting up the unit, what it will make or sell, how the work is done, where the inputs come from, who will buy, where the unit sits and how long it takes to start. A banker reads these first to judge whether the promoter understands the business.

  1. 1. Project at a Glance
  2. 2. Promoter & Enterprise Profile
  3. 3. The Project
  4. 4. Industry Overview
  5. 5. Products and Process
  6. 6. Raw Materials and Utilities
  7. 7. Market and Marketing Strategy
  8. 8. Location and Infrastructure
  9. 9. Implementation Schedule

The money

What the project costs, how it is paid for, the assumptions behind the projections, the yearly profit, cash flow and balance sheet, the loan repayment schedule, and the ratios a lender looks at: debt service coverage, break-even and the key indicators. Every figure flows from the cost of project and the assumptions, so they must agree with each other.

  1. 10. Cost of Project
  2. 11. Means of Finance
  3. 12. Key Assumptions
  4. 13. Projected Profitability Statement
  5. 14. Term Loan Repayment Schedule
  6. 15. Depreciation Schedule
  7. 16. Projected Cash Flow Statement
  8. 17. Projected Balance Sheet
  9. 18. Debt Service Coverage Ratio
  10. 19. Break-Even Analysis
  11. 20. Key Financial Indicators

Risks, approvals and support

An honest SWOT, the licences and registrations the activity needs, the government incentives the unit may claim (named, not counted as income), and a conclusion that states the result of the projections without overstating them.

  1. 21. SWOT Analysis
  2. 22. Statutory Approvals and Registrations
  3. 23. Applicable Government Incentives
  4. 24. Conclusion

Worked example: cost of project and means of finance

Illustrative only. The cost lines are assumptions chosen to show how the statement is built, not typical costs for the sector; the totals, contingency, loan and repayment figures are computed by the same arithmetic as our free DPR builder.

Illustrative cost of project in rupees lakh
Landnone assumed
Building and civil works₹25.00 lakh
Plant and machinery₹50.00 lakh
Other fixed assets (electrical fittings, furniture)₹5.00 lakh
Contingency (5% of building and machinery)₹3.75 lakh
Pre-operative expenses₹3.00 lakh
Margin money for working capital₹15.00 lakh
Cost of project₹101.75 lakh
Term loan (assumed 70% of the cost)₹71.22 lakh
Promoter's contribution₹30.53 lakh
Monthly principal instalment (78 instalments after a 6-month moratorium)₹0.91 lakh
Interest in the first year at 10%₹7.01 lakh

Haryana and Central schemes that may apply

Open schemes an individual unit can claim, tagged in our catalogue for the healthcare, pharmaceutical and medical-device sector, named with each scheme's own ceiling. Whether a unit qualifies depends on its activity, size, location and stage; the eligibility checker tests that and also covers Punjab, Rajasthan and Uttar Pradesh.

Project-level incentives (2)

Capital, interest or tax incentives on the project itself. The report names them under "Applicable Government Incentives" and does not count them as income or as a source of finance until they are sanctioned.

Loans and credit guarantees (3)

Not subsidies: they make the bank loan easier to get and can sit alongside the incentives.

Only if the activity matches (9)

Tagged for this sector in our catalogue but limited to a narrower activity; the condition is shown under each.

  • HaryanaHaryana Pharmaceutical and Medical Devices Manufacturing Policy 2026

    20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr)

    Only if: Only units manufacturing pharmaceutical products (APIs, key starting materials, drug intermediates, bulk drugs, formulations), biologics, biosimilars or medical devices as defined by the Government of India, holding the licences required under the Drugs and Cosmetics Act and the Medical Devices Rules.

    Official source

  • HaryanaHaryana State Startup Policy 2022

    Seed grant up to ₹10 lakh; Net SGST 50% (women-led 100%) for 7 years; patent costs up to ₹25 lakh

    Only if: Only DPIIT-recognised startups registered with Startup Haryana whose registered office is in Haryana (Category 1): a private limited company, registered partnership or LLP up to 10 years old, with turnover never above ₹100 crore, working on innovation.

    Check status: The Supplement of 30 September 2026 added new incentives (technology transfer, micro-grants for women-led startups, exhibitions, quality certification, corporate pilots, seed-fund matching, apprenticeships). Operational schemes for these new items were not on the Department’s website when checked on 20 October 2026, and the Supplement does not say whether it restarts the policy’s five-year term. Confirm with our expert team before applying.

    Official source

  • CentralCredit Guarantee Scheme for Startups

    Guarantee on loans up to ₹20 Crore per startup (85% cover up to ₹10 Crore, 75% above)

    Only if: Only for startups recognised by DPIIT.

    Official source

  • CentralEmergency Credit Line Guarantee Scheme 5.0

    Extra credit up to 20% of peak Q4 FY26 working capital use, capped at ₹100 Crore, 100% guaranteed, nil fee

    Only if: Only for borrowers that already had a working capital limit with a bank or NBFC, with the account standard on 31 March 2026.

    Check status: Guarantees are given first come, first served within the scheme's overall cap of ₹2.50 lakh crore (NCGTC, 18 August 2026), and lenders can sanction only until 31 March 2027. Ask your bank whether cover is still available before you apply.

    Official source

  • CentralExport Promotion Mission – Collateral Support for Export Credit

    Guarantee of up to 85% (micro and small) or 65% (medium) of export-linked working capital

    Only if: Only for MSME exporters of goods whose HSN tariff line is on the DGFT positive list, borrowing export working capital from a member lending institution.

    Check status: DGFT runs this as a pilot. The trade notice sets the limit of ₹10 crore per exporter for 2025-26; we have not confirmed the limit for 2026-27 or the guarantee fee, so ask your bank before relying on them.

    Official source

  • CentralExport Promotion Mission – Interest Subvention on Pre- and Post-Shipment Export Credit

    2.75% a year on rupee export credit, up to ₹50 lakh per exporter a year

    Only if: Only for MSME exporters with an active IEC and Udyam registration, and only on export credit for products whose six-digit HSN tariff line is on the DGFT positive list.

    Check status: DGFT issued these guidelines as a pilot and reviews the rates every six months, so the 2.75% rate and the list of eligible products can change. Check the latest DGFT trade notice before relying on them.

    Official source

  • CentralInternational Cooperation Scheme – Capacity Building of First Time MSE Exporters (CBFTE)

    75% of RCMC fee up to ₹20,000; ECGC premium up to ₹10,000 a year; 75% of testing/certification up to ₹1 lakh

    Only if: Only for micro and small exporters whose Import Export Code was not more than three years old on the date of the export shipment, and who exported in the same financial year.

    Check status: The International Cooperation Scheme was approved for 2021-22 to 2025-26 (to 31 March 2026). A Ministry of MSME memo of 2 April 2026 cites temporary continuation of schemes beyond 31 March 2026, up to 30 September 2026 or until the next scheme is approved, whichever is earlier; when we checked on 20 October 2026 we found no extension beyond that. The IC portal is still active (the Ministry invited trade-fair proposals in October 2026), but we saw no recent notice for this first-time-exporter component, so check with your Export Promotion Council before relying on it.

    Official source

  • CentralMSME Competitive (LEAN) Scheme

    Basic level free; up to ₹1.08 lakh (Intermediate) and ₹2.16 lakh (Advanced) of the consultant cost

    Only if: Intermediate and Advanced levels are taken up by a Group of Enterprises (GoE) formed on the LEAN portal, not by a unit alone.

    Check status: The LEAN guidelines say the scheme's financial support is valid until 31 March 2026. A Ministry of MSME memo of 2 April 2026 cites temporary continuation of schemes beyond 31 March 2026, up to 30 September 2026 or until the next scheme is approved, whichever is earlier; when we checked on 20 October 2026 we found no extension beyond that. The LEAN portal is still active and takes registrations, so confirm there before you commit to a consultant.

    Official source

  • CentralNational SC-ST Hub Scheme (including Special Credit Linked Capital Subsidy)

    25% capital subsidy on plant and machinery, up to ₹25 lakh, plus fee reimbursements

    Only if: Only for micro and small enterprises owned by SC or ST entrepreneurs: an SC/ST proprietor, or at least 51% SC/ST holding in a partnership or company.

    Check status: The National SC-ST Hub guidelines apply until 31 March 2026, and further continuation "shall be subject to review/evaluation". A Ministry of MSME memo of 2 April 2026 cites temporary continuation of schemes beyond 31 March 2026, up to 30 September 2026 or until the next scheme is approved, whichever is earlier; when we checked on 20 October 2026 we found no extension beyond that. The Hub's portal is still active and taking applications, so confirm with your nearest National SC-ST Hub office before you rely on the subsidy.

    Official source

Export incentives (2)

Only if the unit exports or plans to.

Support for particular costs (16)

Each covers one kind of cost (certification, testing, solar, insurance, fairs and similar) with its own application.

Planning a manufacturing unit in Haryana? See what the 2026 policy could pay by project size and area category and the subsidy stacking blueprints.

Questions about a project report for a healthcare or pharma unit

What does a bank look for in a project report for a healthcare or pharma unit?

A complete bank-format report in which the description and the figures agree. For a healthcare or pharma unit the descriptive part should walk through the process (procurement of approved raw materials and packing material from qualified suppliers, through to storage under the specified conditions and dispatch to distributors and buyers), the inputs (active ingredients, excipients, components or consumables approved for the product, and packing material), the utilities and the approvals. The financial part then shows the cost of project, means of finance, projected profitability, cash flow, balance sheet, loan repayment, debt service coverage and break-even. Buyers choose on approved quality, consistent supply, regulatory standing and price.

Which licences and approvals does a healthcare or pharma unit usually need?

Besides Udyam registration, GST registration where turnover or the type of supply requires it, and the power and local-body approvals for the premises, the sector notes in our DPR library list: Manufacturing licence from the State drug control authority, or registration and licence for medical devices under the central regulator, as applicable to the product; Consent to Establish and Consent to Operate from the State Pollution Control Board, where the activity falls within its consent categories; Factory licence under the State factory rules, where applicable; Fire safety no-objection certificate, where required for the building or the materials stored. These are typically required where applicable; whether each applies depends on the size, location and activity of the project, and our expert team confirms it for a specific unit.

What risks will a lender ask about for a healthcare or pharma unit?

Delay in product licences and approvals, met by early filing of applications and professional regulatory support; Quality failures, met by a documented quality system, trained staff and testing of every batch. A report that names its risks and shows how each is handled reads as more credible than one that lists only strengths, and the same points feed the SWOT section of the DPR.

Which Haryana and Central schemes may apply to a healthcare or pharma unit?

Our catalogue lists 32 open Haryana and Central schemes tagged for the healthcare, pharmaceutical and medical-device sector, including Haryana Progressive MSME & Export Promotion Policy 2026 (15–30% of eligible capital expenditure, up to ₹4 Crore) and Make in Haryana Industrial Policy 2026 (Large units: 2.5–20% capital subsidy + 20–70% Net SGST for 7 years). Whether a unit qualifies depends on its activity, size, location and stage, so run the eligibility checker before counting on any of them; Punjab, Rajasthan and Uttar Pradesh schemes are matched there too.

Are the cost figures on this page typical for the sector?

No. They are assumed lines put through the same cost and loan arithmetic as our free DPR builder, to show how the statement is built: contingency at 5% of building and machinery, a term loan of 70% of the cost, 10% interest over 7 years with a 6-month moratorium. Your own report should use your quotations, rent or land figures and the bank's terms.

Can I prepare the project report myself?

Yes. The free DPR builder asks for the project details and costs, pre-fills the healthcare, pharmaceutical and medical-device sector's descriptive text, and produces all 24 sections with the projections, which you can download in Word, PDF or Excel. Before it goes to a bank or a department it should be reviewed by a Chartered Accountant; our expert team can review it or prepare it with you.

Official sources this page relies on

The notifications our catalogue read each listed scheme from, and the registration every scheme asks for. The sector notes above are our own and carry no official figure.

Page checked on 10 November 2026.

Need this project report done? Talk to our expert team

Leave your name and mobile number. Our team calls you back within one working day (Monday to Saturday).

Optional updates and offers

Your details are never sold; they are shared only as our Privacy Policy describes.

Prepare your report

Build a bank-format DPR for a healthcare or pharma unit in the free builder, or ask our expert team to prepare or review it with you.

Build your DPR freeTalk to our expert team

Other sectors: Manufacturing · Food processing · Textiles and garments · IT and ITES · Renewable energy · Agri and livestock processing · Trading and retail · E-commerce and D2C · Logistics and distribution · Tourism and hospitality · Other sectors · All guides

Also useful: GST, TDS and ROC due dates by month.